Provided by Tiger Fintech (Singapore) Pte. Ltd.

SIGA Technologies Inc.

5.64
-0.0100-0.18%
Volume:155.58K
Turnover:846.47K
Market Cap:402.72M
PE:4.72
High:5.73
Open:5.69
Low:5.61
Close:5.69
Loading ...

Company Profile

Company Name:
SIGA Technologies Inc.
Exchange:
NASDAQ
Establishment Date:
1995
Employees:
45
Office Location:
31 East 62nd Street,New York,New York,United States
Zip Code:
10065
Fax:
- -
Introduction:
SIGA Technologies, Inc., a commercial-stage pharmaceutical company, focuses on the health security related markets in the United States. Its lead product is TPOXX, an oral formulation antiviral drug for the treatment of human smallpox disease caused by variola virus. The company was incorporated in 1995 and is headquartered in New York, New York.

Directors

Name
Position
Eric A. Rose
Chairman of the Board and Chief Executive Officer
Andrew L. Stern
Director
Bruce Slovin
Director
James J. Antal
Director
Jeffrey B. Kindler
Director
Joseph W. Marshall, III
Director
Michael J. Bayer
Director
Paul G. Savas
Director
Thomas E. Constance
Director

Shareholders

Name
Position
Eric A. Rose
Chairman of the Board and Chief Executive Officer
Daniel J. Luckshire
Executive Vice President, Chief Financial Officer and Secretary
Dennis E. Hruby
Vice President and Chief Scientific Officer
William J. Haynes
Executive Vice President and General Counsel